Skip to content

Pelvic Floor Exercise Before Surgery in Women With Pelvic Organ Prolapse

Pelvic Floor Exercise Before Surgery in Women With Pelvic Organ Prolapse

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03064750
Acronym
CONTRAPOP
Enrollment
151
Registered
2017-02-27
Start date
2017-01-01
Completion date
2019-06-26
Last updated
2021-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse, Pelvic Floor Disorders

Keywords

Exercise Therapy, Pelvic Floor, Preoperative Care

Brief summary

The lifetime risk for a woman to undergo surgery for either vaginal prolapse or urinary incontinence is high. There are many different surgical techniques for treatment of prolapse, but there is a lack of knowledge about factors that contribute to objective result and patient satisfaction after surgery. The aim of the study is to investigate factors that could be related to patient satisfaction and objective result such as pelvic floor muscle contractility/strength and muscle injury, objective measures of prolapse and women's symptoms. This study will investigate whether systematic pelvic floor exercise and life style advise before surgery can improve outcomes after surgery for either vaginal prolapse. Another aim is to determine an ultrasound scale for measure of pelvic floor muscle contraction.

Interventions

In preparation for surgery, patients receive individual information by a physiotherapist on pelvic floor anatomy and correct pelvic floor contraction. Patients are told to do the following pelvic floor exercises 3 times a day: 8-12 maximal contractions, hold contractions during 10 seconds, and 3 fast contractions after each long contraction. In addition exercise in groups with skilled physical therapists once a week during 12 weeks.

OTHERWaiting list

patients wait as usual until surgery without special treatment.

Sponsors

Norwegian University of Science and Technology
CollaboratorOTHER
St. Olavs Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* referred to surgery for urogenital prolapse * informed consent

Exclusion criteria

* not able to communicate in Norwegian or English * not able or willing to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Pelvic floor muscle strength assessed by palpation9 monthsMuscle strength is evaluated using 6 point modified Oxford Scale (MOS) range 0-5.
Pelvic floor muscle strength assessed by ultrasound9 monthsChanges in pelvic floor muscle at rest and during pelvic floor contraction, measured in mm and calculated proportional change
Symptoms of pelvic floor disorders9 monthsSymptoms of pelvic floor disorders assessed by validated questionnaire (PDFI-20)

Secondary

MeasureTime frameDescription
Proportion of anatomical sphincter ani defect9 monthsAnatomical sphincter ani defect assessed by transperineal ultrasound
Proportion of levator ani muscle trauma9 monthsAssessed by transperineal ultrasound on contraction and Valsalva
Proportion of anatomical pelvic organ prolapse9 monthsAssessment with the Pelvic Organ Prolapse Quantification (POP-Q) System
Imaging of synthetic implants assessed by ultrasound9 monthsRegistration of implants after pelvic floor surgery and their relations to anatomical structures in mm.
Symptoms of pelvic floor disorders9 monthsSymptoms of pelvic floor disorders assessed by validated questionnaire (PFIQ-7)
Assessment of pelvic organ mobility as a measure of pelvic organ function/dysfunction9 monthsMovement of the pelvic organs during Valsalva and contraction
Pelvic floor muscle strength assessed by perineometry9 monthsmeasuring the pressure with vaginal manometry in cm H2O during pelvic floor contraction
Pelvic floor muscle strength assessed by electromyography9 monthsAssessed by vaginal surface electrode during pelvic floor contraction, measured in mV

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026